Longevity Startups

Cavalry Biosciences is a biopharmaceutical company focused on developing medicines that leverage the body's inherent regenerative and repair mechanisms, particularly in areas of age-related disease and tissue regeneration. The company applies translational biology and drug development expertise across multiple therapeutic areas.

3 investors

Chirp provides privacy-preserving home monitoring solutions for seniors using voice-enabled sensors rather than wearables or cameras, allowing caregivers to remotely monitor and support older adults. The company serves family caregivers and senior living communities seeking dignified, non-intrusive monitoring technology.

3 investors

Cirrus Therapeutics is a biotech developing gene and cell therapies based on ocular immunology to treat dry age-related macular degeneration (AMD), including an AAV gene therapy to restore the IRAK-M immune regulator and a next-generation retinal pigment epithelium (RPE) cell therapy for advanced geographic atrophy. It serves patients with chronic blinding eye diseases and operates from Cambridge, Massachusetts and Singapore.

3 investors

ConcertoCare provides coordinated in-home and center-based medical, behavioral, and social care for seniors and adults with complex care needs who have Medicare, Medicare Advantage, or Medicare+Medicaid coverage. As a risk-bearing provider, it uses proprietary care pathways, analytics, and virtual care technology while working alongside patients' existing doctors and benefit plans.

3 investors

Death Clock is a preventive health platform that uses AI to identify early markers of chronic disease and provide actionable health protocols. The platform serves individuals seeking to extend healthspan and prevent disease onset rather than treating illness after diagnosis.

3 investors

Deep Longevity develops AI-powered aging clocks and health analytics tools that estimate biological age and predict long-term health risks using multi-omics data. The company serves healthcare providers, insurers, employers, and wellness platforms seeking to enable preventive, personalized care at scale.

3 investors

Dorian Therapeutics develops therapeutics aimed at rejuvenating tissue and treating age-related diseases. The company operates in the biotech and anti-aging therapeutics space.

3 investors

Elevian is a biotechnology company developing rGDF11, a recombinant protein therapy shown in preclinical animal models to promote recovery of motor function after ischemic and hemorrhagic stroke by stimulating new blood vessel formation, neurogenesis, and reducing inflammation. The protein has also shown regenerative effects in preclinical models of aging-related cardiovascular, neurological, metabolic, pulmonary, renal, and skeletal muscle conditions.

3 investors

Elixir Therapeutics develops therapies for rare diseases and aging-related conditions using proprietary technologies, including ZSCAN4 for telomere extension in stem cell therapies and Bobcat mRNA for delivering large genes. The company is advancing clinical candidates for telomere biology disorders and Duchenne muscular dystrophy.

3 investors

Euler Biologics develops antibody-based therapies aimed at preserving and enhancing physical function in older adults to support healthy aging and functional independence. The company operates in the biotech and longevity space.

3 investors

EVL Bio is developing a selective anti-FGFR4 monoclonal antibody therapy to treat left ventricular hypertrophy (LVH) in patients with chronic kidney disease (CKD). The therapy blocks pathological FGF23–FGFR4 signaling in cardiomyocytes to prevent maladaptive cardiac hypertrophy and fibrosis.

3 investors

Felix is a Canadian digital healthcare platform offering online diagnosis, treatment, and prescription for everyday health needs such as weight loss, mental health, and sexual health. It provides at-home, on-demand care for patients across Canada.

3 investors

FITTR is a fitness coaching platform that provides personalized diet plans and workout programs to help users achieve their health goals. The service targets individuals seeking guidance and accountability for fitness transformation.

3 investors

Freeline develops gene therapies aimed at stopping the progression of chronic diseases with single-dose genetic medicines. Its pipeline spans rare conditions such as Gaucher disease and moves toward more widespread conditions including forms of Parkinson's, dementia, and certain cardiovascular diseases.

3 investors

Gather Health provides primary care services with integrated social and home-based support for older adults in underserved communities. The company operates physical centers that combine medical care with community programs focused on connection, education, and wellness.

3 investors

Geron is a biopharmaceutical company focused on developing therapies for blood cancer. The company has over 30 years of experience in research and clinical development.

3 investors

A wellness brand curator and ecosystem builder that creates, acquires, and nurtures companies focused on longevity and well-being, offering products ranging from supplements to superfoods. The company serves consumers seeking improved health outcomes and meaningful living across mind, body, and community.

3 investors

Groove provides a virtual bone health program for people with osteoporosis, pairing each member with a physician and a dedicated physical therapist for at-home strength training and monitoring. The service targets older adults in the U.S. and is covered by Original Medicare.

3 investors

HarborSite develops a targeted gene insertion platform that engineers site-specific recombinase enzymes to integrate therapeutic genes into safe genomic sites. It aims to create one-time, durable treatments for genetic and age-associated diseases.

3 investors

Himedi arranges comprehensive medical checkups at vetted clinics in Seoul, South Korea, covering imaging, endoscopy, cancer and longevity markers in a single morning visit. It targets international travelers to Korea, offering self-serve package booking, focus-area upgrades (heart, brain, cancer), and a take-home report.

3 investors

Hydrostasis develops technology focused on helping aging adults maintain health through hydration monitoring, leveraging expertise in optical technology, data science, and biology.

3 investors

A biotechnology company, founded in 2013, developing regenerative medicine technologies including methods to differentiate stem cells into cardiovascular cells and hydrogel-particle-based layering techniques. Its foundational technologies originate from academic research in Japan.

3 investors

InsideTracker provides personalized health insights by analyzing biological markers and genetic data to deliver customized recommendations for nutrition, fitness, and lifestyle optimization for individuals seeking longevity and preventive wellness.

3 investors

Integrated Biosciences is a biotech company developing small molecule therapeutics for age-related diseases, using optogenetics, chemistry, and AI to study aging biology. It operates an integrated drug discovery platform combining synthetic biology, chemical data, and machine learning.

3 investors